NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has achieved a major milestone with its first reimbursement payment from Anthem Blue Cross Blue Shield for its innovative PoNS Device. This marks a crucial step in expanding access to the non-invasive technology designed for patients with multiple sclerosis (MS).
The payment, totaling $15,420, covers the PoNS controller and mouthpiece at an out-of-network adjusted price point. Helius views this reimbursement as a strong indicator of the therapeutic and economic value of the PoNS Device, setting an important precedent for future coverage negotiations with insurance providers.
This milestone comes as Helius continues to advocate for expanded insurance coverage and appeals to the Centers for Medicare & Medicaid Services (CMS) to adjust current payment rates. By securing broader third-party reimbursement, the company aims to enhance patient accessibility to its technology and deepen its impact on the MS community.
The sum reimbursed by Anthem, including patient co-payment, reflects a benchmark as Helius engages with other major commercial insurers. Despite being an out-of-network payment, typically 30 to 40 percent lower than in-network rates, the reimbursement underscores confidence in the device’s value and paves the way for future growth.
Helius remains committed to increasing accessibility and offering innovative solutions to improve the lives of MS patients while advancing its market presence in the medical device sector.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.